Cargando…
Prostaglandin E2 and Receptors: Insight Into Tumorigenesis, Tumor Progression, and Treatment of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a common primary liver cancer with ∼750,000 annual incidence rates globally. PGE2, usually known as a pro-inflammatory cytokine, is over-expressed in various human malignancies including HCC. PGE2 binds to EP receptors in HCC cells to influence tumorigenesis or enha...
Autores principales: | Chen, Chao, Guan, Jun, Gu, Xinyu, Chu, Qingfei, Zhu, Haihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959932/ https://www.ncbi.nlm.nih.gov/pubmed/35356289 http://dx.doi.org/10.3389/fcell.2022.834859 |
Ejemplares similares
-
Uncovering the Association Between m(5)C Regulator-Mediated Methylation Modification Patterns and Tumour Microenvironment Infiltration Characteristics in Hepatocellular Carcinoma
por: Gu, Xinyu, et al.
Publicado: (2021) -
Multi-Omics Characterizes the Effects and Mechanisms of CD1d in Nonalcoholic Fatty Liver Disease Development
por: Zheng, Qiuxian, et al.
Publicado: (2022) -
Glycogen Phosphorylase B Is Regulated by miR101-3p and Promotes Hepatocellular Carcinoma Tumorigenesis
por: Cui, Guangying, et al.
Publicado: (2020) -
Connexin 43 hemichannels and prostaglandin E(2) release in anabolic function of the skeletal tissue to mechanical stimulation
por: Zhao, Dezhi, et al.
Publicado: (2023) -
Novel Insights in the Regulatory Mechanisms of Ferroptosis in Hepatocellular Carcinoma
por: Ma, Shiwen, et al.
Publicado: (2022)